Handler joins Bezeq controlling shareholder Shaul Elovitch and Yes CEO Ron Eilon on the list of those questioned in the Bezeq-Yes affair.
One source told "Globes": The Bezeq-Yes deal contains everything that can be wrong about a party at interest transaction.
70% of employees are women says the Nisha placement company. Salaries are generous but not as high as in IT.
Banks are making absurd demands of new immigrants and freezing banks accounts of those unable to comply.
The ISA needs to prove its case and make an example of Bezeq on insider transactions.
Using robots to handle the most mundane work will free up people to focus on more important and creative tasks, argues Harel Tayeb.
Israeli firms at the Viva Technology Show displayed software taking over what we assumed were exclusively human preserves.
The entire concept of balance is disappearing from the political scene in the US and much of Europe.
Israeli defense industry sources say that terrorism in Europe is creating opportunities for deals.
Aerospace & defense
Cathay exec Paul Loo says he's not in the low-cost game, and advises Israeli hotels not to offer Chinese tourists Chinese food.
Proneuron claims in its legal battle with Teva that the Israeli pharmaceutical giant refused to consider lower dosage Copaxone.
Having an excellent product is not enough without online marketing knowhow, quality manufacturing and distribution, and infrastructure, explains Alexey Chalimov.
Martin Saidler plans an Israel R&D center for his fintech company Centralway and wants to invest in Israeli startups.
The TSX has appointed Yossi Boker to lead business development in Israel. He and TSX chief client officer Shaun McIver tell "Globes" about the advantages of the TSX.